Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Molecular Devices Launches Axon Digidata 1550 Low-Noise Data Acquisition System

Published: Thursday, May 09, 2013
Last Updated: Thursday, May 09, 2013
Bookmark and Share
High performance, high throughput system designed to support the most challenging electrophysiology research.

Molecular Devices® has announced the launch of its next generation Axon™ Digidata® 1550 Low-Noise Data Acquisition System. Considered the industry standard in neuroscience research labs, the new Digidata Platform enables the parallel patching of up to eight cells simultaneously to provide better insight of neuronal network function and capture more data points per experiment.  This new system extends the precision and quality of the existing Axon Digitizer platform to include a higher sampling rate to monitor rapid responders, combined with enhanced performance in low-noise, high resolution 16-bit data acquisition.DD-1550-Angle-lo.gif

The Digidata 1550 Digitizer features eight independent analog output channels to simultaneously send command waveforms to multiple cells at one time, essential for higher throughput toxicology experiments or to study synaptic function in complex neuronal networks. Combined with a sampling rate of up to 500 kHz per channel, the Digidata 1550 Digitizer allows researchers to gather more data points in demanding experiments such as nanopore and bilayer studies. This rapid rate monitors the fastest of signals in the biorelevant frequency range, whilst achieving a total data throughput rate of 4 mega-samples per second. Independent analog-to-digital converters for each input channel also ensure low crosstalk levels and high data acquisition rates, making the system one of the quietest digitizers on the market.

Designed for intuitive set-up and fast results, the Digidata 1550 Digitizer comes with AxoScope Data Acquisition Software for Microsoft Windows OS (Windows 7 32- or 64-bit) and is ready to acquire data immediately after installation - absolutely no programming is necessary.

Klaus Lun, Vice President of Product Marketing at Molecular Devices commented: "The Digidata 1550 Digitizer builds on Molecular Devices' experience in electrophysiology and biophysical research fields. Our commitment to bring additional utility to the conventional electrophysiology hardware and software allows our customers further understanding of neuronal networks, allowing researchers to make better, quicker decisions based on robust data.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Devices Partners with Roche
Partnership will develop custom Ruthenium Nano-TRF Detection Platform.
Thursday, November 06, 2014
Molecular Devices Becomes Global Distributor of IonFlux
Molecular Devices makes deal with Fluxion Biosciences to distribute their automated electrophysiology systems and associated products.
Tuesday, May 28, 2013
Molecular Devices Forms Scientific Advisory Board
Multidisciplinary team will guide product and application development to deliver maximum value to customers.
Thursday, December 27, 2012
Molecular Devices to attend ADME & Predictive Toxicology Europe
Company is to showcase its SpectraMax® Paradigm® microplate reader during the European conference in Munich, Germany, 13-14 March 2012.
Wednesday, February 29, 2012
Molecular Devices Awarded Patent for Population Patch Clamp Recording Technique
The parallel recording technique measures ionic currents from a population of cells, rather than single cells, on planar patch clamp systems and enhances ion channel assay success rates to near 100%.
Tuesday, January 10, 2012
Registration opens for RNAi and High Content Imaging 2011
Molecular Devices Inc. announces that they have opened registration for its RNAi & High Content Imaging Symposium 2011, to be held at the Oxford Spires Four Pillars, Oxford on 1st April 2011.
Tuesday, February 08, 2011
Molecular Devices Launches New Products & Customer-Focused Brand at Society for Biomolecular Sciences Meeting
New IonWorks Barracuda™ Automated High-Speed Patch Clamp System & AquaMax® 2000/4000 Microplate Washer 96 Cell-Wash Head
Thursday, April 08, 2010
Scientific News
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos